Search Within

Christopher G Azzoli

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (6)
Groups
  1. Advanced Practice Providers (15)
  2. Department of Medicine (15)
  3. Nursing (15)
  4. Solid Tumor Oncology Division (15)
  5. Thoracic Oncology (15)
  6. Survivorship Research (13)

More Groups

People
  1. Mark Kris (15)
  2. Lee Krug (12)
  3. Megan Dunne (11)
  4. Leslie Tyson (10)
  5. Vincent Miller (10)
  6. Naiyer Rizvi (8)

More People

Years
  1. 2013 (1)
  2. 2012 (2)
  3. 2011 (2)
  4. 2007 (4)
  5. 2006 (1)
  6. 2005 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Clinical Cancer Research (3)
  3. Journal of Thoracic Oncology (3)
  4. Cancer (2)
  5. Lung Cancer (1)
  6. Molecular Cancer Therapeutics (1)
Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (4)
  3. Elsevier Inc. (3)
  4. Wiley Blackwell (2)
  5. Elsevier Ireland Ltd. (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of paclitaxel, pemetrexed and bevacizumab in patients with untreated, advanced lung cancers
    Meeting Abstract

    Pietanza, M. C.; Hellmann, M. D.; Rizvi, N.; Azzoli, C. G.; Smith-Marrone, S.; Fiore, J.; Tyson, L. B.; Sumner, D. K.; Hergianto, A. B.; Kass, S. L.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker
    Journal Article

    Pietanza, M. C.; Kadota, K.; Huberman, K.; Sima, C. S.; Fiore, J. J.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; Holodny, A. I.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
    Meeting Abstract

    D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Phase I study of the antifolate pralatrexate given with vitamin B(12) and folic acid supplementation in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Krug, L.; Miller, V.; Bekele, S.; Tyson, L.; Dunne, M.; Huntington, M.; Saunders, M.; Kris, M. G.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    James, L. P.; Azzoli, C. G.; Krug, L. M.; Miller, V.; Tripathi, P.; Subzwari, S.; Tyson, L. B.; Dunne, M.; Huntington, M. F.; Saunders, M. E.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Rizvi, N. A.; Kris, M. G.; Dunne, M.; Farmer, A.; Pizzo, B.; Tyson, L.; Seeger, T.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • A Phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer
    Journal Article

    Milton, D. T.; Azzoli, C. G.; Heelan, R. T.; Venkatraman, E.; Gomez, J. E.; Kris, M. G.; Krug, L. M.; Pao, W.; Rizvi, N. A.; Dunne, M.; more...
    Cancer (2006)

    Fulltext@MSK | Save